Autoplaque vs Ultrasound Workspace (UWS 6.0)
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is precise, AI-driven quantitative analysis of coronary artery plaque and luminal stenoses specifically from CT angiography images. This tool is ideal for clinicians focused on detailed plaque characterization and stenosis measurement to inform heart attack risk prediction and guide treatment strategies based on CT findings.
View Autoplaque →Choose Ultrasound Workspace (UWS 6.0) if…
Choose Ultrasound Workspace (UWS 6.0) if you require a holistic, AI-powered system for streamlining echocardiography workflows, enhancing diagnostic confidence, and ensuring high reproducibility. This solution is particularly well-suited for environments needing vendor-neutral data analysis, comprehensive cardiovascular review, and integrated reporting across various ultrasound platforms.
View Ultrasound Workspace (UWS 6.0) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Ultrasound Workspace (UWS 6.0) |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On-premise (single-seat workstation, multi-seat server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ultrasound Workspace (UWS 6.0)Philips Ultrasound Workspace (Tool B) offers superior usability due to its web-based access and vendor-neutral data analysis, allowing for remote image review and consistent diagnostic capabilities across various environments and equipment. In contrast, Autoplaque (Tool A) is described as workstation-based software, which typically offers less flexibility and accessibility for modern clinical workflows.
Clinical Value
AutoplaqueAutoplaque (Tool A) provides AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, directly aiding in heart attack risk prediction and treatment guidance, which is a high-impact clinical application. While Ultrasound Workspace (Tool B) enhances diagnostic confidence and reproducibility in echocardiography, Autoplaque's specific focus on predicting future cardiac events from plaque characteristics offers a distinct and critical clinical advantage.
Pricing & Value
TieNeither Autoplaque (Tool A) nor Ultrasound Workspace (Tool B) disclose their pricing information in the provided facts or readily available online sources. Both require direct contact with their respective companies for pricing details, making a head-to-head comparison on this dimension impossible.
Enterprise Readiness
Ultrasound Workspace (UWS 6.0)Ultrasound Workspace (Tool B) demonstrates strong enterprise readiness with explicit statements of HIPAA compliance, BAA availability, integration with existing PACS and EMR systems, and a scalable technology platform with flexible licensing models. Autoplaque (Tool A) lacks disclosed information regarding HIPAA compliance, BAA, or integration capabilities, and its workstation-based deployment suggests a potentially less scalable solution for large enterprises.
Innovation
AutoplaqueAutoplaque (Tool A), developed by Cedars-Sinai AIM, offers highly specialized AI-powered quantitative analysis of coronary plaques from CT angiography for heart attack risk prediction, including characterization of dangerous plaque types. This specific focus on predictive analytics from detailed plaque morphology represents a cutting-edge application of AI in cardiology. While Ultrasound Workspace (Tool B) offers innovative vendor-neutrality and comprehensive automated echo measurements, Autoplaque's direct link to personalized risk prediction from CT data stands out as a more novel and potentially transformative innovation.
Support & Docs
Ultrasound Workspace (UWS 6.0)Philips, as a large global health technology company, provides comprehensive support and documentation for its products, including Ultrasound Workspace (Tool B), with readily available user information and technical support details. Autoplaque (Tool A), originating from an academic medical center, does not have easily discoverable commercial-grade support and documentation information, suggesting a less formalized support structure for external users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Ultrasound Workspace (UWS 6.0) |
|---|---|---|
| Company | Cedars-Sinai Medical Center: AIM | Philips Ultrasound |
| Primary Application/Focus | Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Holistic, scalable, AI-powered cardiovascular viewing, analysis, and reporting system designed to streamline echocardiography workflows, enhance diagnostic confidence, and improve reproducibility. |
| Key AI-powered Capabilities | Quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, automated vessel, plaque, and lumen segmentation. | Automated measurements (e.g., Auto Measure, AutoStrain LV, 3D Auto RV, 3D Auto MV, 3D Auto TV, 3D Auto CFQ). |
| Data Analysis Scope | Coronary anatomy and pathology from CT Angiographic images. | Vendor-neutral and multi-vendor data analysis for standardization in echocardiography. |
| Integration | Not specified | Integration with existing PACS and EMR systems. |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Ultrasound Workspace (UWS 6.0).